These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2808478)

  • 1. Improved use of buthionine sulfoximine to prevent cisplatin nephrotoxicity in rats.
    Mayer RD; Lee KE; Cockett AT
    J Cancer Res Clin Oncol; 1989; 115(5):418-22. PubMed ID: 2808478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor.
    Mayer RD; Lee KE; Cockett AT
    Cancer Chemother Pharmacol; 1987; 20(3):207-10. PubMed ID: 2890443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buthionine sulfoximine (BSO) and N-(3,5-dichlorophenyl)succinimide nephrotoxicity: temporal aspects of BSO administration and BSO effects on renal transport systems.
    Rankin GO; Beers KW; Teets VJ; Nicoll DW; Anestis DK
    Toxicology; 1997 Feb; 117(2-3):207-17. PubMed ID: 9057900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of glutathione for cisplatin nephrotoxicity in young and adult rats.
    Appenroth D; Winnefeld K
    Ren Fail; 1993; 15(2):135-9. PubMed ID: 8469780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of buthionine sulfoximine on acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Fischer 344 rats.
    Rankin GO; Teets VJ; Nicoll DW; Brown PI
    Toxicol Lett; 1990 Jun; 52(1):91-100. PubMed ID: 2356574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of buthionine sulfoximine on N-(3,5-dichlorophenyl)-2-hydroxysuccinimide and N-(3,5-dichlorophenyl)-2-hydroxysuccinamic acid nephrotoxicity.
    Rankin GO; Teets VJ; Nicoll DW; Brown PI
    Toxicol Lett; 1991 Aug; 57(3):297-308. PubMed ID: 1882389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal glutathione depletion and nephrotoxicity of cadmium-metallothionein in rats.
    Suzuki CA; Cherian MG
    Toxicol Appl Pharmacol; 1989 May; 98(3):544-52. PubMed ID: 2718180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats.
    Standeven AM; Wetterhahn KE
    Pharmacol Toxicol; 1991 Jun; 68(6):469-76. PubMed ID: 1891442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against cisplatin toxicity by administration of glutathione ester.
    Anderson ME; Naganuma A; Meister A
    FASEB J; 1990 Nov; 4(14):3251-5. PubMed ID: 2227215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of glutathione depletion by L-buthionine-S,R-sulfoximine on gentamicin nephrotoxicity in rats.
    Wu DF; Griffith OW; Reidenberg MM
    Pharmacology; 1990; 40(5):250-7. PubMed ID: 2274571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P; Loh SY; Kelland LR; Harrap KR
    Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
    Mizutani T; Ito K; Nomura H; Nakanishi K
    Food Chem Toxicol; 1990 Mar; 28(3):169-77. PubMed ID: 2344991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of glutathione depletion by buthionine sulphoximine on 1-cyano-3,4-epithiobutane toxicity.
    VanSteenhouse JL; Fettman MJ; Gould DH
    Food Chem Toxicol; 1991 Mar; 29(3):153-7. PubMed ID: 2032656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of depletion of nonprotein sulfhydryls by diethyl maleate plus buthionine sulfoximine on renal uptake of mercury in the rat.
    Baggett JM; Berndt WO
    Toxicol Appl Pharmacol; 1986 May; 83(3):556-62. PubMed ID: 3705075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on the effects of BSO, GSH, vitamin C and DMPS on the nephrotoxicity induced by mercury].
    Zhao-Fa X; Jing-Hua Y; Jia-Ming Y; Zhong-Wei Y
    Wei Sheng Yan Jiu; 2005 Sep; 34(5):533-6. PubMed ID: 16329589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.